Evidence map›Paper›PMID 25379726›Full record

ArticlePloS one2014

Development of a mimotope vaccine targeting the Staphylococcus aureus quorum sensing pathway.

John P O'Rourke, Seth M Daly, Kathleen D Triplett, David Peabody, Bryce Chackerian, Pamela R Hall

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Critical Assessment of the Prospects of Quorum-Quenching Therapy forInternational journal of molecular sciences · 2023
    Review
  3. Article
  4. Review
  5. Article
  6. Quorum Sensing as Antivirulence Target in Cystic Fibrosis Pathogens.International journal of molecular sciences · 2019
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Interfering with Bacterial Quorum Sensing.Perspectives in medicinal chemistry · 2016
    Article
  14. Review
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

John P O'RourkeDepartment of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, NM, United States of America.
Seth M DalyDepartment of Pharmaceutical Sciences, University of New Mexico School of Medicine, Albuquerque, NM United States of America.
Kathleen D TriplettDepartment of Pharmaceutical Sciences, University of New Mexico School of Medicine, Albuquerque, NM United States of America.
David PeabodyDepartment of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, NM, United States of America.
Bryce ChackerianDepartment of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, NM, United States of America.
Pamela R HallDepartment of Pharmaceutical Sciences, University of New Mexico School of Medicine, Albuquerque, NM United States of America.
University of New Mexico · US

Funding

Biology of Infectious Diseases &InflammationT32AI007538 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Michelle A Ozbun · 1998 to 2026
$5.2M
Apolipoprotein B and Control of S. aureus Quorum SensingR01AI091917 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI HALL, PAMELA RANEL · 2011 to 2015
$1.9M
A VLP-based platform for Vaccine DiscoveryR01AI083305 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI CHACKERIAN, BRYCE C · 2010 to 2013
$1.2M
NIAID NIH HHS R01 AI083305NIAID NIH HHS R01 AI091917NIAID NIH HHS T32 AI007538NIAID NIH HHS T32-AI007538
6 · The paper itself

Abstract

A major hurdle in vaccine development is the difficulty in identifying relevant target epitopes and then presenting them to the immune system in a context that mimics their native conformation. We have engineered novel virus-like-particle (VLP) technology that is able to display complex libraries of random peptide sequences on a surface-exposed loop in the coat protein without disruption of protein folding or VLP assembly. This technology allows us to use the same VLP particle for both affinity selection and immunization, integrating the power of epitope discovery and epitope mimicry of traditional phage display with the high immunogenicity of VLPs. Previously, we showed that using affinity selection with our VLP platform identifies linear epitopes of monoclonal antibodies and subsequent immunization generates the proper antibody response. To test if our technology could identify immunologic mimotopes, we used affinity selection on a monoclonal antibody (AP4-24H11) that recognizes the Staphylococcus aureus autoinducing peptide 4 (AIP4). AIP4 is a secreted eight amino acid, cyclized peptide produced from the S. aureus accessory gene regulator (agrIV) quorum-sensing operon. The agr system coordinates density dependent changes in gene expression, leading to the upregulation of a host of virulence factors, and passive transfer of AP4-24H11 protects against S. aureus agrIV-dependent pathogenicity. In this report, we identified a set of peptides displayed on VLPs that bound with high specificity to AP4-24H11. Importantly, similar to passive transfer with AP4-24H11, immunization with a subset of these VLPs protected against pathogenicity in a mouse model of S. aureus dermonecrosis. These data are proof of principle that by performing affinity selection on neutralizing antibodies, our VLP technology can identify peptide mimics of non-linear epitopes and that these mimotope based VLP vaccines provide protection against pathogens in relevant animal models.

Indexed as

Biomimetic MaterialsAmino Acid SequenceAnimalsBacterial ProteinsBacterial VaccinesEpitopesFeasibility StudiesFemaleMicePeptides, CyclicQuorum SensingStaphylococcus aureusAgrD protein, StaphylococcusBacterial ProteinsBacterial VaccinesEpitopesPeptides, Cyclic

Identifiers

PMID25379726
PMCPMC4224382
OpenAlexW2065795968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.